Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin?

Introduction

Mealtime Insulin, challenges, and New Standard Management.

Objectives

Highlight the current challenges in mealtime insulin management
Help understand why ultra rapid acting lispro could be the new standard of Mealtime insulin management
Reinforce patient profiles suitable for ultra-rapid acting lispro

This Course For :

Physician ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )
Resident / Fellow ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General practitioner )

Speaker

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 03 May 2023    To    03 May 2023
  • 07:00 PM  To  08:00 PM
  • Certificate Available
  • Online Click Here
  • 623
  Add to Calendar 05/03/2023 07:00 PM 05/03/2023 08:00 PM Asia/ Riyadh Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin? Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin? https://medicalacademy.org/portal/event/view/1949
Should Ultra Rapid Acting Analogs be the New Standard of Mealtime Insulin?